Glycemic Response to Six Meal Replacements in Persons With Type 2 Diabetes Mellitus
| Status: | Recruiting |
|---|---|
| Conditions: | Diabetes, Diabetes |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 20 - 75 |
| Updated: | 5/17/2017 |
| Start Date: | April 11, 2017 |
| End Date: | May 31, 2017 |
| Contact: | Kemuel Reyes |
| Email: | Kemuel.Reyes@us.nestle.com |
| Phone: | 908-333-9242 |
Plasma Glucose and Insulin Response to Six Meal Replacements in Persons With Type 2 Diabetes Mellitus
This will be a randomized, cross-over design. Subjects will be randomized to one of six
interventions on six separate study days, 1 week apart.
interventions on six separate study days, 1 week apart.
Inclusion Criteria:
- Age 20-75 yrs
- Type 2 diabetes controlled with diet or diet and oral agent, with the exception of
sulfonylureas such as glimepiride (Amaryl), glipizide (Glucotrol/Glucotrol XL) and
glyburide (DiaBeta, Micronase, Glynase Prestabs); meglitinides such as reaglinide
(Prandin) and nateglinide (Starlix); and alpha-glucosidase inhibitors such as
acarbose (Precose) and miglitol (Glyset)
- Hemoglobin A1C less than 9.0%
- Fasting blood glucose less than 180 mg
- Hematocrit levels within normal limits
Exclusion Criteria:
- Abnormal thyroid function
- Creatinine >2.0 mg/dL
- Potassium <3.5 mEq/L
- Gastrointestinal disease: ulcer, gastritis, diarrhea, gastroparesis, vomiting
- Currently unstable diabetes or under treatment for cancer, heart disease, renal
disease
- Unable to give informed consent or follow instructions
- Current insulin therapy or insulin therapy within the past month
- Patient who are pregnant
- Allergies to milk, soy or any component of the test product
- Patient who in the Investigators assessment cannot be expected to comply with
treatment
- Currently participating or having participated in another clinical trial.
- Patients with Anemia
We found this trial at
1
site
Click here to add this to my saved trials
